Abemaciclib (trade names Verzenio, Verzenios and Ramiven) is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6.|Metastatic breast cancer only
Details below.
Signup today to claim your Discount. Get Started before it's too late!
